Immunological and inflammatory biomarkers, including IL-1β, IL-6, TNF-α, IL-10, IL-8, IL-17, and CRP, have become indispensable tools in stroke research, offering insight into how the immune system shapes both the extent of brain injury and the trajectory of recovery [6,8,9,30]. This evidence concerns the gene CRP and stroke disorder.